Kbc Group Nv Glaukos Corp Transaction History

Kbc Group Nv

$37 Billion
Q2 2025

A detailed history of Kbc Group Nv transactions in Glaukos Corp stock. As of the latest transaction made, Kbc Group Nv holds 1,689 shares of GKOS stock, worth $134,224. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,689

Previous 2,416 30.09%

Holding current value

$134,224

Previous $238,000 26.89%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$82.27 - $103.29 $59,810 - $75,091	-727 Reduced 30.09%	1,689 $174,000
Q1 2025 Apr 25, 2025	SELL	$96.6 - $161.22 $96 - $161	-1 Reduced 0.04%	2,416 $238,000
Q4 2024 Jan 22, 2025	BUY	$126.42 - $152.67 $122,880 - $148,395	972 Added 67.27%	2,417 $362,000
Q3 2024 Nov 06, 2024	BUY	$113.62 - $135.39 $22,837 - $27,213	201 Added 16.16%	1,445 $188,000
Q2 2024 Jul 17, 2024	BUY	$89.48 - $118.35 $18,164 - $24,025	203 Added 19.5%	1,244 $147,000
Q4 2023 Feb 13, 2024	SELL	$59.53 - $85.11 $150,134 - $214,647	-2,522 Reduced 70.78%	1,041 $83,000
Q3 2023 Feb 15, 2024	SELL	$69.23 - $79.09 $166,498 - $190,211	-2,405 Reduced 67.5%	1,158 $87,000
Q2 2023 Feb 15, 2024	SELL	$45.44 - $71.21 $30,399 - $47,639	-669 Reduced 15.81%	3,563 $254,000
Q2 2023 Jul 28, 2023	SELL	$45.44 - $71.21 $16,676 - $26,134	-367 Reduced 9.34%	3,563 $254,000
Q1 2023 Feb 14, 2024	SELL	$43.88 - $52.48 $13,251 - $15,848	-302 Reduced 7.14%	3,930 $197,000
Q1 2023 May 04, 2023	SELL	$43.88 - $52.48 $13,251 - $15,848	-302 Reduced 7.14%	3,930 $197,000
Q3 2022 Feb 15, 2024	BUY	$46.84 - $58.49 $149,466 - $186,641	3,191 Added 306.53%	4,232 $225,000
Q2 2022 Feb 14, 2024	SELL	$34.86 - $63.77 $188,104 - $344,102	-5,396 Reduced 56.04%	4,232 $192,000
Q2 2022 Jul 26, 2022	SELL	$34.86 - $63.77 $188,104 - $344,102	-5,396 Reduced 56.04%	4,232 $192,000
Q1 2022 Feb 14, 2024	SELL	$44.33 - $57.82 $97,038 - $126,567	-2,189 Reduced 18.52%	9,628 $557,000
Q1 2022 May 06, 2022	SELL	$44.33 - $57.82 $97,038 - $126,567	-2,189 Reduced 18.52%	9,628 $557,000
Q4 2021 Feb 14, 2024	BUY	$40.27 - $56.99 $433,949 - $614,124	10,776 Added 1035.16%	11,817 $525,000
Q3 2021 Nov 10, 2021	BUY	$47.43 - $84.23 $456,276 - $810,292	9,620 Added 437.87%	11,817 $569,000
Q2 2021 Aug 11, 2021	BUY	$73.06 - $97.7 $61,954 - $82,849	848 Added 62.86%	2,197 $186,000
Q4 2020 Feb 10, 2021	BUY	$48.9 - $75.26 $65,966 - $101,525	1,349 New	1,349 $102,000

Others Institutions Holding GKOS

# of Institutions

330

Shares Held

54.3M

Call Options Held

259K

Put Options Held

481K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $3.78B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account